GlassScriptPhysician profile
Miguel Damien
NPI 1821025925
$1,575.29
in general payments reported to CMS, 2019-2025
12 companies · $157 in 2025
The $157 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $140 · 2021: $389 · 2022: $190 · 2023: $299 · 2024: $102 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $674.78 | 2019-2025 | Menopur |
| Abbvie INC. | $193.77 | 2019-2022 | |
| Emd Serono, INC. | $178.46 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $177.89 | 2023-2025 | Myfembree |
| Organon LLC | $112.93 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $92.41 | 2019-2021 | |
| Pfizer INC. | $51.66 | 2022-2023 | |
| Coopersurgical, INC. | $35.95 | 2021 | |
| Myovant Sciences INC. | $17.14 | 2022 | |
| Ethicon US, LLC | $13.99 | 2021 | |
| Daiichi Sankyo INC. | $13.69 | 2022 | |
| Hologic Sales and Service, LLC | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Damien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.